The Government of Canada has announced the 156 new and renewed Canada Research Chairs, and we are thrilled to share that CHÉOS Scientists Drs. Eugenia Oviedo-Joekes and Anne Gadermann are among them.
Dr. Oviedo-Joekes, a professor at UBC’s School of Population and Public Health, was appointed as a Tier 1 Canada Research Chair in Person-Centered Care in Addiction and Public Health. She will investigate how Canadian health care systems can best address the diverse needs of people who struggle with opioid use. Dr. Oviedo-Joekes and her research team aim to pioneer new approaches to treatments, such as injectable opioid agonist treatment (iOAT). Read about some of her current research into the use of iOAT as treatment for opioid use disorder.
Dr. Gadermann, an assistant professor at UBC’s School of Population and Public Health, was appointed as a Tier 2 Canada Research Chair in Bio-Eco-Social Determinants of Child and Youth Mental Health. She will collaborate with the government, community, and clinical partners to explore how social, biological, and environmental influences can impact the mental health of children and youth. Alongside her team, Dr. Gadermann hopes to generate knowledge that will inform interventions and policies to support this population. Read about some of her recent work on how COVID-19 has impacted students and teachers.
CHÉOS is also home to Canada Research Chairs Drs. Linda Li, Rick Sawatzky, Mary De Vera, and Martin Schechter.
The Canada Research Chair program invests millions of dollars each year to top researchers across the country to reinforce academic research and training excellence in Canadian post-secondary institutions. Chairholders are ideally positioned to improve our knowledge and understanding of their specialized topics and help train the next generation of researchers through supervision, teaching, and research coordination.
Click here to find out more.
